Artículo de opiniónEfectos adversos de los inhibidores de la 5-alfa-reductasa en la alopecia androgenética masculina ¿hay por qué preocuparse?Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?
Bibliografía (27)
- et al.
A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia
J Am Acad Dermatol
(2014) - et al.
Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia
Urology
(2003) Persistent sexual side effects of finasteride: Could they be permanent?
J Sex Med
(2012)- et al.
Incomplete recovery of erectile function in rat after discontinuation of dual 5-alpha reductase inhibitor therapy
J Sex Med
(2012) - et al.
Androgenetic alopecia as an early marker of benign prostatic hyperplasia
J Am Acad Dermatol
(2012) - et al.
Androgenetic alopecia and risk of prostate cancer: A systematic review and meta-analysis
J Am Acad Dermatol
(2013) - et al.
Male breast cancer and 5α-reductase inhibitors finasteride and dutasteride
J Urol
(2013) - et al.
Androgenetic alopecia and cardiovascular risk factors in men and women: A comparative study
J Am Acad Dermatol
(2010) - et al.
Finasteride attenuates pathological gambling in patients with Parkinson disease
J Clin Psychopharmacol
(2012) - et al.
Efficacy and safety of finasteride therapy for androgenetic alopecia: A systematic review
Arch Dermatol
(2010)
A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia: Finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride
Int J Clin Pract
(2012)
Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
Rev Endocr Metab Disord
(2015)
Persistent sexual dysfunction and suicidal ideation in young men treated with low-dose finasteride: A pharmacovigilance study
Pharmacotherapy
(2015)
Cited by (0)
© 2016 AEDV. Published by Elsevier España, S.L.U. All rights reserved.